733 related articles for article (PubMed ID: 36064525)
1. Safety of beta-blocker and calcium channel blocker antihypertensive drugs in pregnancy: a Mendelian randomization study.
Ardissino M; Slob EAW; Rajasundaram S; Reddy RK; Woolf B; Girling J; Johnson MR; Ng FS; Gill D
BMC Med; 2022 Sep; 20(1):288. PubMed ID: 36064525
[TBL] [Abstract][Full Text] [Related]
2. Maternal hypertensive traits and adverse outcome in pregnancy: a Mendelian randomization study.
Ardissino M; Reddy RK; Slob EAW; Griffiths J; Girling J; Ng FS
J Hypertens; 2023 Sep; 41(9):1438-1445. PubMed ID: 37432894
[TBL] [Abstract][Full Text] [Related]
3. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy.
Abalos E; Duley L; Steyn DW; Gialdini C
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD002252. PubMed ID: 30277556
[TBL] [Abstract][Full Text] [Related]
4. Maternal Hypertension Increases Risk of Preeclampsia and Low Fetal Birthweight: Genetic Evidence From a Mendelian Randomization Study.
Ardissino M; Slob EAW; Millar O; Reddy RK; Lazzari L; Patel KHK; Ryan D; Johnson MR; Gill D; Ng FS
Hypertension; 2022 Mar; 79(3):588-598. PubMed ID: 35138876
[TBL] [Abstract][Full Text] [Related]
5. The effects of blood pressure and antihypertensive drugs on heart failure: A Mendelian randomization study.
Li Y; Xiao W; Huang N; Zhuang Z; Zhang L; Wang W; Song Z; Zhao Y; Dong X; Xu M; Huang T
Nutr Metab Cardiovasc Dis; 2023 Jul; 33(7):1420-1428. PubMed ID: 37156668
[TBL] [Abstract][Full Text] [Related]
6. Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis.
Yarmolinsky J; Díez-Obrero V; Richardson TG; Pigeyre M; Sjaarda J; Paré G; Walker VM; Vincent EE; Tan VY; Obón-Santacana M; Albanes D; Hampe J; Gsur A; Hampel H; Pai RK; Jenkins M; Gallinger S; Casey G; Zheng W; Amos CI; ; ; ; Smith GD; Martin RM; Moreno V
PLoS Med; 2022 Feb; 19(2):e1003897. PubMed ID: 35113855
[TBL] [Abstract][Full Text] [Related]
7. Genetically predicted blood pressure, antihypertensive drugs and risk of heart failure: a Mendelian randomization study.
Lian J; Shi X; Jia X; Fan J; Wang Y; Zhao Y; Yang Y
J Hypertens; 2023 Jan; 41(1):44-50. PubMed ID: 36129112
[TBL] [Abstract][Full Text] [Related]
8. Genetically determined blood pressure, antihypertensive medications, and risk of intracranial aneurysms and aneurysmal subarachnoid hemorrhage: A Mendelian randomization study.
Liu H; Zuo H; Johanna O; Zhao R; Yang P; Chen W; Li Q; Lin X; Zhou Y; Liu J
Eur Stroke J; 2024 Mar; 9(1):244-250. PubMed ID: 37800876
[TBL] [Abstract][Full Text] [Related]
9. Genetic proxies for antihypertensive drugs and mental disorders: Mendelian randomization study in European and East Asian populations.
Fan B; Zhao JV
BMC Med; 2024 Jan; 22(1):6. PubMed ID: 38166843
[TBL] [Abstract][Full Text] [Related]
10. [Assessment of antihypertensive monotherapies effectiveness by home blood pressure self-measurement in hypertensive patients].
Hanon O; Laroche P; Vidal JS; Pannier B; Postel-Vinay N; Vaisse B; Girerd X
Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):218-23. PubMed ID: 22695025
[TBL] [Abstract][Full Text] [Related]
11. Association of Hypertensive Disorders of Pregnancy With Future Cardiovascular Disease.
Rayes B; Ardissino M; Slob EAW; Patel KHK; Girling J; Ng FS
JAMA Netw Open; 2023 Feb; 6(2):e230034. PubMed ID: 36800181
[TBL] [Abstract][Full Text] [Related]
12. Association between antihypertensive drugs and hepatocellular carcinoma: A trans-ancestry and drug-target Mendelian randomization study.
Wang Z; Lu J; Hu J
Liver Int; 2023 Jun; 43(6):1320-1331. PubMed ID: 37005366
[TBL] [Abstract][Full Text] [Related]
13. Exploring the causal relationship between antihypertensive drugs and glioblastoma by combining drug target Mendelian randomization study, eQTL colocalization, and single-cell RNA sequencing.
Zhao S; Xie Y; Ding X; Zheng C; Chen J; Zhao N; Ji Y; Wang Q; Liu Y; Cheng C
Environ Toxicol; 2024 Jun; 39(6):3425-3433. PubMed ID: 38450887
[TBL] [Abstract][Full Text] [Related]
14. Genetic variation in the beta2 subunit of the voltage-gated calcium channel and pharmacogenetic association with adverse cardiovascular outcomes in the INternational VErapamil SR-Trandolapril STudy GENEtic Substudy (INVEST-GENES).
Niu Y; Gong Y; Langaee TY; Davis HM; Elewa H; Beitelshees AL; Moss JI; Cooper-Dehoff RM; Pepine CJ; Johnson JA
Circ Cardiovasc Genet; 2010 Dec; 3(6):548-55. PubMed ID: 21156931
[TBL] [Abstract][Full Text] [Related]
15. Genetically determined blood pressure, antihypertensive medications, and risk of Alzheimer's disease: a Mendelian randomization study.
Ou YN; Yang YX; Shen XN; Ma YH; Chen SD; Dong Q; Tan L; Yu JT
Alzheimers Res Ther; 2021 Feb; 13(1):41. PubMed ID: 33563324
[TBL] [Abstract][Full Text] [Related]
16. Associations between lipid-lowering drugs and pregnancy and perinatal outcomes: a Mendelian randomization study.
Wang R; Zhao J; Li L; Huo Y
J Hypertens; 2024 Apr; 42(4):727-734. PubMed ID: 38230624
[TBL] [Abstract][Full Text] [Related]
17. Hypertension, antihypertensive drugs, and age at onset of Huntington's disease.
Zhu Y; Li M; Bai J; Wang H; Huang X
Orphanet J Rare Dis; 2023 May; 18(1):125. PubMed ID: 37226269
[TBL] [Abstract][Full Text] [Related]
18. Using genetics to assess the association of commonly used antihypertensive drugs with diabetes, glycaemic traits and lipids: a trans-ancestry Mendelian randomisation study.
Zhao JV; Liu F; Schooling CM; Li J; Gu D; Lu X
Diabetologia; 2022 Apr; 65(4):695-704. PubMed ID: 35080656
[TBL] [Abstract][Full Text] [Related]
19. Artist® tablets (carvedilol) for hypertensive patients in Japan: results of a drug use survey.
Mori Y; Nishikawa Y; Iizuka T; Zenimura N; Matsumoto T; Hiramatsu K; Komiya M
Drugs R D; 2011; 11(2):171-90. PubMed ID: 21679007
[TBL] [Abstract][Full Text] [Related]
20. Genetically Predicted Blood Pressure and Risk of Atrial Fibrillation.
Hyman MC; Levin MG; Gill D; Walker VM; Georgakis MK; Davies NM; Marchlinski FE; Damrauer SM
Hypertension; 2021 Feb; 77(2):376-382. PubMed ID: 33390040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
